Slice-selective learning for Alzheimer’s disease classification using a generative adversarial network: a feasibility study of external validation

Purpose The aim of this feasibility study was to use slice selective learning using a Generative Adversarial Network for external validation. We aimed to build a model less sensitive to PET imaging acquisition environment, since differences in environments negatively influence network performance. To investigate the slice performance, each slice evaluation was performed. Methods We trained our model using a 18F-fluorodeoxyglucose ([ 18 F]FDG) PET/CT dataset obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database and tested the model with a Severance Hospital dataset. We applied slice selective learning to reduce computational cost and to extract unbiased features. We extracted features of Alzheimer’s disease (AD) and normal cognitive (NC) condition using a Boundary Equilibrium Generative Adversarial Network (BEGAN) for stable convergence. Then, we utilized these features to train a support vector machine (SVM) classifier to distinguish AD from NC. Results The slice range that covered the posterior cingulate cortex (PCC) using double slices showed the best performance. The accuracy, sensitivity, and specificity of our proposed network was 94.33%, 91.78%, and 97.06% using the Severance dataset and 94.82%, 92.11%, and 97.45% using the ADNI dataset. The performance on the two independent datasets showed no statistical difference ( p  > 0.05). Moreover, there was a statistical difference in the performance between using two slices and one slice as input ( p  < 0.05). Conclusions Our model learned the generalized features of AD and NC for external validation when appropriate slices were selected. This study showed the feasibility of this model with consistent performance when tested using datasets acquired from a variety of image-acquisition environments.

[1]  W. Jagust,et al.  The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 , 2015, Alzheimer's & Dementia.

[2]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[3]  S. de Santi,et al.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. , 2010, Journal of Alzheimer's disease : JAD.

[4]  I. Buvat,et al.  Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.

[5]  R. Boellaard Standards for PET Image Acquisition and Quantitative Data Analysis , 2009, Journal of Nuclear Medicine.

[6]  Tanya Glozman,et al.  Hidden Cues : Deep Learning for Alzheimer ’ s Disease Classification CS 331 B project final report , 2016 .

[7]  Saad Rehman,et al.  A deep CNN based multi-class classification of Alzheimer's disease using MRI , 2017, 2017 IEEE International Conference on Imaging Systems and Techniques (IST).

[8]  J. Ashburner,et al.  Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.

[9]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[10]  Danni Cheng,et al.  Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer’s Disease Diagnosis , 2018, Neuroinformatics.

[11]  Ayman El-Baz,et al.  Alzheimer's disease diagnostics by adaptation of 3D convolutional network , 2016, 2016 IEEE International Conference on Image Processing (ICIP).

[12]  Karl J. Friston,et al.  Spatial Normalization Nonlinear Spatial Normalization Using Basis Functions Spatial Normalization Spatial Normalization Spatial Normalization Spatial Normalization Spatial Normalization Spatial Normalization Spatial Normalization 2.1 the Basic Optimization Algorithm 1 C a from This We Can Derive an , 1999 .

[13]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[14]  Geoffrey E. Hinton,et al.  ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.

[15]  Dinggang Shen,et al.  Deep Learning-Based Feature Representation for AD/MCI Classification , 2013, MICCAI.

[16]  Rachel L. Mistur,et al.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  J. Powers,et al.  Practice guidelines for autopsy pathology. Autopsy procedures for brain, spinal cord, and neuromuscular system. Autopsy Committee of the College of American Pathologists. , 1995, Archives of pathology & laboratory medicine.

[18]  David Berthelot,et al.  BEGAN: Boundary Equilibrium Generative Adversarial Networks , 2017, ArXiv.

[19]  Simon Osindero,et al.  Conditional Generative Adversarial Nets , 2014, ArXiv.

[20]  Sidong Liu,et al.  Multimodal Neuroimaging Feature Learning for Multiclass Diagnosis of Alzheimer's Disease , 2015, IEEE Transactions on Biomedical Engineering.

[21]  A. Drzezga,et al.  Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  Syed Muhammad Anwar,et al.  Deep Learning in Medical Image Analysis , 2017 .

[23]  Yoshua Bengio,et al.  Generative Adversarial Networks , 2014, ArXiv.